angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Lung Neoplasms

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, ZJ; Elias, PD; Harding, JW; Hudson, BD; Masino, JA; McCoy, AT; Sardinia, MF; Varnum, MD; Wright, JW; Yamamoto, BJ	1

Other Studies

1 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Lung Neoplasms

Article	Year
The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:1 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dogs; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hepatocyte Growth Factor; Humans; In Vitro Techniques; Lung; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Proto-Oncogene Proteins c-met; Radioligand Assay; Signal Transduction	2010

Article

Year

The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor.

The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:1

Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dogs; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hepatocyte Growth Factor; Humans; In Vitro Techniques; Lung; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Proto-Oncogene Proteins c-met; Radioligand Assay; Signal Transduction

2010